Research Use Only

21+ Age Verification

How2Pep is an independent, research-grade peptide reference. Nothing here is medical advice or approved for human consumption. To enter, confirm you are 21 years of age or older and provide your email.

Your email is stored to verify access and comply with research-use documentation. We do not sell or share your information.

SingleGrowth Hormone

CJC-1295 DAC 5mg

Long-acting synthetic GHRH analog paired with Drug Affinity Complex to sustain growth hormone release in laboratory models.

Mechanism

The peptide binds selectively to pituitary somatotroph GHRH receptors, while its Drug Affinity Complex covalently tethers to serum albumin to maintain persistent, non-pulsatile secretion of growth hormone and downstream IGF-1.

Dosing

Published experimental handling outlines an initial investigative baseline of 300 mcg administered twice weekly, titrating systematically according to study criteria.

Reconstitution

Reconstituting the 5 mg lyophilized powder with 2.0 mL of bacteriostatic water yields a finished working concentration of 2.5 mg/mL (25 mcg per U-100 unit).

Storage

Store the unmixed lyophilized vial at -20 °C, and once reconstituted, maintain the solution between 2 °C and 8 °C protected from light without refreezing.

Mix & measure CJC-1295 DAC 5mg

Pre-filled with this protocol's recommended BAC water and documented starting dose — edit any field to run your own numbers.

Mix & measure CJC-1295 DAC 5mg

Vial strength → BAC water → target dose

mL
Concentration2.50mg/mL
Draw volume0.120mL
On the syringe12.0units

Total doses in vial: 16.7

100u80u60u40u20u0

U-100 syringe: 100 units = 1 mL

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Advanced calculator →

Dosing Chart

Phase / Day(s)Dose & FrequencyVolume (U-100 units / mL)
Weeks 1–2300 mcg (0.3 mg) twice weekly12 units (0.12 mL)
Weeks 3–4500 mcg (0.5 mg) twice weekly20 units (0.20 mL)
Weeks 5–6750 mcg (0.75 mg) twice weekly30 units (0.30 mL)
Weeks 7–121000 mcg (1 mg) twice weekly40 units (0.40 mL)

Reconstitution Steps

  1. 1

    Draw 2.0 mL of bacteriostatic water into a sterile syringe.

  2. 2

    Release it slowly down the vial's inner wall to limit foaming.

  3. 3

    Swirl or roll gently until fully dissolved — don't shake.

  4. 4

    Label with the date and concentration, then refrigerate at 2–8 °C (35.6–46.4 °F), shielded from light.

Supplies Needed

Peptide Vial

Peptide Vial

CJC-1295 DAC 5 mg lyophilized peptide

Insulin Syringes (U-100)

Insulin Syringes (U-100)

1 mL U-100 syringes for measurement and administration

Bacteriostatic Water

Bacteriostatic Water

Diluent for peptide reconstitution (2.0 mL per vial)

Alcohol Swabs

Alcohol Swabs

Sanitizing vial stoppers and preparation sites

Why researchers study it

1

GH & IGF-1 support

2

Body composition & lipolysis

3

Tissue repair & recovery

4

Sleep & slow-wave activity

These describe what is being studied, not proven benefits, approved uses, or promised results.

Overview

CJC-1295 DAC is a synthetic growth-hormone-releasing hormone derivative engineered with a Drug Affinity Complex modification. This specific functional group binds covalently to endogenous serum albumin following administration, markedly slowing renal filtration and enzymatic breakdown compared to native hormones. As a consequence of this prolonged circulation, experimental settings observe a persistent, non-pulsatile elevation of growth hormone and insulin-like growth factor 1, often contrasted with the transient secretory pulses created by standard peptide formulations. In investigative biochemistry, this continuous activation provides an experimental framework for analyzing downstream somatotropic signaling without necessitating daily dosing schedules. Researchers explore the resulting cascade to observe physiological adaptations involving cellular nitrogen retention, lipid mobilization pathways, and peripheral tissue remodeling. The compound serves as an important benchmark in the study of structural half-life enhancement and pituitary receptor occupancy.

References

  1. 1.Teichman SL et al., J Clin Endocrinol Metab, 2006 — Prolonged stimulation of GH and IGF-1 secretion by CJC-1295
  2. 2.Ionescu M, Frohman LA, J Clin Endocrinol Metab, 2006 — Pulsatile and continuous effects on GH and IGF-1 elevation
  3. 3.Alba M et al., Am J Physiol Endocrinol Metab, 2006 — Mechanistic GHRH-receptor activation in knockout animal models
  4. 4.Ayuk J, Sheppard MC, Postgrad Med J, 2006 — Growth hormone physiology and excessive GH/IGF-1 signaling

Supplies Needed

Suggested supplier

Research use only. Listing a supplier is not an endorsement of any protocol on this site, and nothing sold there is approved for human use.

How2Pep

An independent, research-grade peptide reference library. Reconstitution, dosing, and storage protocols — evidence-referenced and not affiliated with any vendor.

Notice

Research use only. Nothing on this site is medical advice or approved for human consumption. Protocols reference peer-reviewed data where available.

© 2026 How2Pep · Independent reference

Admin

Educational research information only.